(Q37672247)

21 August 2017

1 reference

title

Urine biomarkers in prostate cancer (English)

1 reference

21 August 2017

0 references

1 reference

1

Guillaume Ploussard

1 reference

PubMed ID

20065953

21 August 2017

Alexandre de la Taille

series ordinal

2

object named as

Alexandre de la Taille

1 reference

PubMed ID

20065953

21 August 2017

language of work or name

English

0 references

publication date

12 January 2010

1 reference

21 August 2017

Nature Reviews Urology

1 reference

21 August 2017

7

1 reference

21 August 2017

2

1 reference

21 August 2017

101-109

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2009.261

21 August 2017

0 references

cites work

Quantitative GSTP1 Methylation and the Detection of Prostate Adenocarcinoma in Sextant Biopsies

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Detection of alpha-methylacyl-coenzyme-A racemase transcripts in blood and urine samples of prostate cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Golgi protein GOLM1 is a tissue and urine biomarker of prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Proteomics for the identification of new prostate cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Estimates of the cancer incidence and mortality in Europe in 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

31 March 2020

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Mortality results from a randomized prostate-cancer screening trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Screening and prostate-cancer mortality in a randomized European study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Methylation-specific sequencing of GSTP1 gene promoter in circulating/extracellular DNA from blood and urine of healthy donors and prostate cancer patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Prostate cancer molecular markers GSTP1 and hTERT in expressed prostatic secretions as predictors of biopsy results

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

DNA-based detection of prostate cancer in urine after prostatic massage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Quantitative GSTP1 hypermethylation in bodily fluids of patients with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

The usefulness of the detection of GSTP1 methylation in urine as a biomarker in the diagnosis of prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Molecular Detection of Localized Prostate Cancer Using Quantitative Methylation-Specific PCR on Urinary Cells Obtained Following Prostate Massage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Multicenter evaluation of an investigational prostate cancer methylation assay

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Noninvasive detection of genetic instability in cells from prostatic secretion as a marker of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

The use of PCA3 in the diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

PCA3: a molecular urine assay for predicting prostate biopsy outcome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

PCA3 molecular urine assay for prostate cancer in men undergoing repeat biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

PCA3 molecular urine assay correlates with prostate cancer tumor volume: implication in selecting candidates for active surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

ETS gene fusions in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Noninvasive detection of TMPRSS2:ERG fusion transcripts in the urine of men with prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Detection of TMPRSS2-ERG fusion transcripts and prostate cancer antigen 3 in urinary sediments may improve diagnosis of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

A novel diagnostic test for prostate cancer emerges from the determination of alpha-methylacyl-coenzyme a racemase in prostatic secretions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

A duplex quantitative polymerase chain reaction assay based on quantification of alpha-methylacyl-CoA racemase transcripts and prostate cancer antigen 3 in urine sediments improved diagnostic accuracy for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Prostate cancer detection on urinalysis for alpha methylacyl coenzyme a racemase protein

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Delineation of prognostic biomarkers in prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

The role of SPINK1 in ETS rearrangement-negative prostate cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Can urinary exosomes act as treatment response markers in prostate cancer?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Postcoital detection of a male-specific semen protein. Application to the investigation of rape

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

An analysis of urinary prostate specific antigen before and after radical prostatectomy: evidence for secretion of prostate specific antigen by the periurethral glands

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Urinary/serum prostate-specific antigen ratio: comparison with free/total serum prostate-specific antigen ratio in improving prostate cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

The use of telomerase activity for the detection of prostatic cancer cells after prostatic massage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasia

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Annexin A3 in urine: a highly specific noninvasive marker for prostate cancer early detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

New functions for the matrix metalloproteinases in cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Proteome analysis of gelatin-bound urinary proteins from patients with bladder cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Discovery and validation of urinary biomarkers for prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Evaluation of Serum and Urinary Myeloid Related Protein-14 as a Marker for Early Detection of Prostate Cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Identification of extracellular delta-catenin accumulation for prostate cancer detection

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

c-Met: structure, functions and potential for therapeutic inhibition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

c-met proto-oncogene expression in benign and malignant human prostate tissues

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Urine analysis and protein networking identify met as a marker of metastatic prostate cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Development of a sensitive and specific enzyme-linked immunosorbent assay for thymosin beta15, a urinary biomarker of human prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Serum and urinary prostatic inhibin-like peptide in benign prostatic hyperplasia and carcinoma of prostate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Diagnosis of Genito-Urinary Tract Cancer by Detection of Minichromosome Maintenance 5 Protein in Urine Sediments

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Preliminary evaluation of 5 alpha-reductase type 2 in urine as a potential marker for prostate disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Urinary tissue factor levels in prostatic carcinoma: a potential marker of metastatic spread?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Urinary tissue factor levels in patients with bladder and prostate cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

A preliminary study of urinary transferrin as a marker for prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

The diagnostic value of urinary transferrin compared to serum prostatic specific antigen (PSA) and prostatic acid phosphatase (PAP) in patients with prostatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Molecular PCA3 diagnostics on prostatic fluid

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2009.261

Telomerase activity: a prevalent marker of malignant human prostate tissue.

31 March 2020

1 reference

12 December 2020

Prostate cancer detection by GSTP1 methylation analysis of postbiopsy urine specimens.

1 reference

12 December 2020

Can molecular markers now be used for early diagnosis of malignancy?

1 reference

12 December 2020

DD3: a new prostate-specific gene, highly overexpressed in prostate cancer

1 reference

12 December 2020

Rapid and quantitative detection of human septin family Bradeion as a practical diagnostic method of colorectal and urologic cancers.

1 reference

12 December 2020

Urinary PSA: a potential useful marker when serum PSA is between 2.5 ng/mL and 10 ng/mL.

1 reference

12 December 2020

Molecular detection of prostate cancer in urine by GSTP1 hypermethylation

1 reference

12 December 2020

Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2009.261

1 reference

21 August 2017

1 reference

PubMed ID

20065953